Medication or usual support for depression identified after orthopaedic surgery
About this title
Read the official source — NCT05976347Researchers are comparing Fluoxetine 20 MG and Duloxetine 30 MG to find out how the approaches affect depression symptoms in people with depression.
Understand this study
What is this study about?
Researchers are comparing Fluoxetine 20 MG and Duloxetine 30 MG to find out how the approaches affect depression symptoms in people with depression.
Who could participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
- Listed locations
- Winston-SalemSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 100
- Sponsor
- Wake Forest University Health Sciences
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT05976347
- Official title
Show the full official title
Identifying and Treating Depression in the Orthopaedic Trauma Population
Recruitment & locations
Winston-Salem
Interested in joining this study?
Questions about this study
What is this study about?
Researchers are comparing Fluoxetine 20 MG and Duloxetine 30 MG to find out how the approaches affect depression symptoms in people with depression.
Who is behind this study?
The study sponsor is Wake Forest University Health Sciences, a university.
Does this study involve medication?
Yes. The study involves medication, including Fluoxetine 20 MG and Duloxetine 30 MG.
Who can participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
